Pérez V - Search Results

1

Benefits of a Secondary Prevention Program in Suicide.

Farré A, Portella MJ, De Angel L, Díaz A, de Diego-Adeliño J, Vegué J, Duran-Sindreu S, Faus G, Tejedor C, Álvarez E, Pérez V. Farré A, et al. Among authors: perez v. Crisis. 2016 Jul;37(4):281-289. doi: 10.1027/0227-5910/a000388. Epub 2016 Jun 1. Crisis. 2016. PMID: 27245810 Clinical Trial.

2

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.

Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F. Pérez V, et al. Lancet. 1997 May 31;349(9065):1594-7. doi: 10.1016/S0140-6736(96)08007-5. Lancet. 1997. PMID: 9174562 Clinical Trial.

3

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F. Pérez V, et al. Arch Gen Psychiatry. 1999 Apr;56(4):375-9. doi: 10.1001/archpsyc.56.4.375. Arch Gen Psychiatry. 1999. PMID: 10197835 Clinical Trial.

4

Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors.

Pérez V, Puiigdemont D, Gilaberte I, Alvarez E, Artigas F; Grup de Recerca en Trastorns Afectius. Pérez V, et al. J Clin Psychopharmacol. 2001 Feb;21(1):36-45. doi: 10.1097/00004714-200102000-00008. J Clin Psychopharmacol. 2001. PMID: 11199945 Clinical Trial.

5

[Olanzapine and cognitive-behavioural group therapy in borderline personality disorder].

Soler J, Campins MJ, Pérez V, Puigdemont D, Pérez-Blanco E, Alvarez E. Soler J, et al. Among authors: perez v, perez blanco e. Actas Esp Psiquiatr. 2001 Mar-Apr;29(2):85-90. Actas Esp Psiquiatr. 2001. PMID: 11333525 Spanish.

6

Preliminary evidence of striatal D2 receptor density as a possible biological marker of prognosis in naive schizophrenic patients.

Pérez V, Catafau AM, Corripio I, Martín JC, Alvarez E. Pérez V, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):767-70. doi: 10.1016/s0278-5846(03)00106-4. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12921907

7

Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.

Corripio I, Catafau AM, Perez V, Puigdemont D, Mena E, Aguilar Y, Carrió I, Alvarez E. Corripio I, et al. Among authors: perez v. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):91-6. doi: 10.1016/j.pnpbp.2004.10.010. Epub 2004 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15610950 Clinical Trial.

8

Is grey literature essential for a better control of publication bias in psychiatry? An example from three meta-analyses of schizophrenia.

Martin JL, Pérez V, Sacristán M, Alvarez E. Martin JL, et al. Among authors: perez v. Eur Psychiatry. 2005 Dec;20(8):550-3. doi: 10.1016/j.eurpsy.2005.03.011. Epub 2005 Jul 1. Eur Psychiatry. 2005. PMID: 15994063

9

Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.

Corripio I, Pérez V, Catafau AM, Mena E, Carrió I, Alvarez E. Corripio I, et al. Among authors: perez v. Neuroimage. 2006 Jan 15;29(2):662-6. doi: 10.1016/j.neuroimage.2005.07.038. Epub 2005 Aug 19. Neuroimage. 2006. PMID: 16112587

10

Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia.

Martin JL, Pérez V, Sacristán M, Rodríguez-Artalejo F, Martínez C, Alvarez E. Martin JL, et al. Among authors: perez v. Eur Psychiatry. 2006 Jan;21(1):11-20. doi: 10.1016/j.eurpsy.2005.09.009. Epub 2005 Dec 27. Eur Psychiatry. 2006. PMID: 16380237 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,299 results

Search Page